A Randomized, Double-Blind, Parallel-group, Placebo-Controlled comparison of omeprazole 20 mg once daily, omeprazole 10 mg, and placebo in adult patients (18 – 80 years of age) with healed endoscopically-diagnosed gastro esophageal reflux disease (GERD) for 1 year or until relapse.
Study identifier:I-653-B
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
A Randomized, Double-Blind, Parallel-group, Placebo-Controlled comparison of omeprazole 20 mg once daily, omeprazole 10 mg, and placebo in adult patients (18 – 80 years of age) with healed endoscopically-diagnosed gastro esophageal reflux disease (GERD) for 1 year or until relapse.
Medical condition
Acid Reflux
Phase
N/A
Healthy volunteers
-
Study drug
-
Sex
-
Actual Enrollment
-
Study type
Interventional
Age
-
Date
Study Start Date: 01 Jan 1971
Primary Completion Date: -
Study Completion Date: -
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Dec 2013 by AstraZeneca
Sponsors
AstraZeneca
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
